| Drug Name: | Crizanlizumab |
|---|
| Drug Class: | Monoclonal antibody |
|---|
| Mechanism of Action: | - Binds to P-selectin, preventing platelet-endothelial cell adhesion and subsequent vaso-occlusion
|
|---|
| Use: | - Prevention of vaso-occlusive crises in patients with sickle cell disease
|
|---|
| Side Effects: | - Nausea
- Back pain
- Fever
- Arthralgia
- Diarrhea
- Abdominal pain
|
|---|
| Contraindications: | |
|---|
| Specialty: | |
|---|